Results 91 to 100 of about 20,149 (219)
Enteroviruses (EVs and RVs) are prevalent worldwide and cause various diseases in humans, of which the VP1-pocket is a target of antivirals, with a lipid molecule as a pocket factor to stabilize the virion.
Xiaojing Lin +7 more
doaj +1 more source
Discovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against Enteroviruses [PDF]
Jun Zuo +5 more
openalex +1 more source
ABSTRACT Background From 2016 to 2018, the World Health Organization (WHO) initiated a global RSV surveillance pilot program in 14 countries, expanding to 25 countries from 2019 to 2023. As part of this, a sequencing program was introduced to improve the understanding of RSV global genetic diversity prior to and following the introduction of ...
Obadiah Kenji +12 more
wiley +1 more source
ABSTRACT Background Quantifying the burden of respiratory syncytial virus (RSV) in adults is challenging compared to influenza, and data among older adults remain scarce in Japan. Country‐specific evidence is essential to support RSV vaccination policy.
Haruka Maeda +24 more
wiley +1 more source
Genotyping of enteroviruses isolated in Kenya from pediatric patients using partial VP1 region [PDF]
Silvanos Opanda +4 more
openalex +1 more source
The seasonality of nonpolio enteroviruses in the United States: Patterns and drivers
Margarita Pons-Salort +6 more
openalex +2 more sources
Enteroviral 3C protease cleaves N4BP1 to impair the host inflammatory response
Enteroviral 3C protease (3Cpro) is an essential enzyme for viral replication and is responsible for combating the host anti-viral immune response by targeting cellular proteins for cleavage.
Dongjie Zhang +4 more
doaj +1 more source

